No difference between aspirin and warfarin after extracardiac Fontan in a propensity score analysis of 475 patients.

@article{Iyengar2016NoDB,
  title={No difference between aspirin and warfarin after extracardiac Fontan in a propensity score analysis of 475 patients.},
  author={Ajay Iyengar and David S Winlaw and John C. Galati and Gavin R. Wheaton and Thomas L. Gentles and Leeanne E. Grigg and Robert N. Justo and Dorothy J. Radford and Chantal Attard and Robert G. Weintraub and Andrew M Bullock and Gary S Sholler and David S Celermajer and Yves d'Udekem},
  journal={European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery},
  year={2016},
  volume={50 5},
  pages={
          980-987
        }
}
OBJECTIVES The most effective method of long-term thromboprophylaxis after the Fontan procedure is not clear. We compared the rates of thromboembolic events between patients receiving aspirin and warfarin after an extracardiac conduit Fontan procedure in a bi-national registry. METHODS All patients who underwent an extracardiac conduit Fontan procedure from 1997 to 2010 in Australia and New Zealand were identified. Medication status and routine follow-up and echocardiographic data were… CONTINUE READING
View on PubMed
Open Access
1
Twitter Mention

Topics from this paper.

Explore Further: Topics Discussed in This Paper